Cargando…
The CD36-PPARγ Pathway in Metabolic Disorders
Uncovering the biological role of nuclear receptor peroxisome proliferator-activated receptors (PPARs) has greatly advanced our knowledge of the transcriptional control of glucose and energy metabolism. As such, pharmacological activation of PPARγ has emerged as an efficient approach for treating me...
Autores principales: | Maréchal, Loïze, Laviolette, Maximilien, Rodrigue-Way, Amélie, Sow, Baly, Brochu, Michèle, Caron, Véronique, Tremblay, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983591/ https://www.ncbi.nlm.nih.gov/pubmed/29883404 http://dx.doi.org/10.3390/ijms19051529 |
Ejemplares similares
-
A Concerted Kinase Interplay Identifies PPARγ as a Molecular Target of Ghrelin Signaling in Macrophages
por: Demers, Annie, et al.
Publicado: (2009) -
SUN-077 In Utero Growth Restriction Induces an Early Metabolic Shift in Fetal Rat Heart
por: Maréchal, Loïze, et al.
Publicado: (2019) -
Hexarelin Signaling to PPAR [Formula: see text] in Metabolic Diseases
por: Demers, Annie, et al.
Publicado: (2008) -
Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis
por: Ferret-Sena, Véronique, et al.
Publicado: (2022) -
Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis
por: Zheng, Qian-Wen, et al.
Publicado: (2021)